Yajing Q. Xu

87 Xiangya Road
Changsha, 410008, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 72 publications

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Journal: Bone marrow transplantation

Published: August 31, 2026

Visualizing NO2-/NAD(P)H metabolic crosstalk in E. coli-infected bladder cancer via a dual-responsive probe.

Visualizing NO2-/NAD(P)H metabolic crosstalk in E. coli-infected bladder cancer via a dual-responsive probe.

Journal: Chemical communications (Cambridge, England)

Published: July 09, 2026

Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities.

Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities.

Journal: Bone marrow transplantation

Published: April 05, 2026

Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China.

Reliability and validity of EuroQol-5 Dimensions-5 Levels in patients with haematologic malignancies: a cross-sectional study in China.

Journal: BMJ open

Published: March 19, 2026

Agreement between the EQ-5D-5L anxiety/depression dimension and GAD-7/PHQ-9 for psychological distress assessment in patients with hematologic malignancies.

Agreement between the EQ-5D-5L anxiety/depression dimension and GAD-7/PHQ-9 for psychological distress assessment in patients with hematologic malignancies.

Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation

Published: March 11, 2026

Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide in Patients With Large Paroxysmal Nocturnal Hemoglobinuria Clones.

Allogeneic Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide in Patients With Large Paroxysmal Nocturnal Hemoglobinuria Clones.

Journal: European journal of haematology

Published: February 11, 2026

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD.

The safety and efficacy of belumosudil and ruxolitinib combination in ruxolitinib refractory cGVHD.

Journal: Bone marrow transplantation

Published: November 27, 2025

Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.

Phase I/II Trial of the FLT3 Kinase Inhibitor XY0206 in Patients With Relapsed/Refractory Acute Myeloid Leukemia.

Journal: European journal of haematology

Published: October 10, 2025

Fatty acid metabolic signature reveals FASN as an immunosuppressive factor in DLBCL tumor microenvironment.

Fatty acid metabolic signature reveals FASN as an immunosuppressive factor in DLBCL tumor microenvironment.

Journal: Medical oncology (Northwood, London, England)

Published: June 04, 2025

NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study.

NUP98 Rearrangement Dynamics Predict Outcomes in Adult Patients With Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Real-World Study.

Journal: Transplantation and cellular therapy

Published: May 17, 2025

Author Correction: Correlation between intestinal CRE colonization and consequent systemic infection in hospitalized patients in China.

Author Correction: Correlation between intestinal CRE colonization and consequent systemic infection in hospitalized patients in China.

Journal: Scientific reports

Published: February 28, 2025

The Aberrantly Expressed Nuclear Factor (Erythroid-derived 2)-Like 2 Participates in aGVHD by Modulating the Activation and Differentiation of CD4 + T Lymphocytes.

The Aberrantly Expressed Nuclear Factor (Erythroid-derived 2)-Like 2 Participates in aGVHD by Modulating the Activation and Differentiation of CD4 + T Lymphocytes.

Journal: Transplantation

Published: February 07, 2025

Showing 1-12 of 72

Last Updated: 09/26/2026